OpenScience.ink

Hot New Top

2 weeks ago • Science (New York, N.Y.)

Psychedelics as preventive brain protectorsPsychedelics as prophylactic neuroprotectants.

Comment

2 weeks ago • Recherche en soins infirmiers

[Not Available].[Not Available].

English Abstract

2 weeks ago • The Canadian journal of urology

Article

2 weeks ago • Journal of psychoactive drugs

Hallucinogen Use and Health Issues Among US Adults with Justice System Involvement, Including Other Drug Use and Demographic LinksJustice Involvement and Hallucinogen Use Among US Adults: Exploring Health Problems, Other Substance Use, and Demographic Correlates.

Article

2 weeks ago • Journal of psychoactive drugs

Age and Cannabis Use Are Linked to Differences in Psilocybin Experience and Perceived BenefitsAge and Cannabis Co-Use Are Associated with Differences in Experience and Perceived Benefits of Psilocybin: A Retrospective Study.

Article

2 weeks ago • JAMA psychiatry

Repeated Ketamine Treatments for Hard-to-Treat Bipolar Depression: A Randomized Clinical TrialSerial Ketamine Infusions for Treatment-Resistant Bipolar Depression: A Randomized Clinical Trial.

🥇 Top 1% JournalArticle

2 weeks ago • Nature communications

How the connection between thinking, memory, and emotion areas relates to brain changes in antidepressant responseThe mPFC-reuniens-hippocampus pathway links brain circuitry and neural plasticity in antidepressant response.

🥈 Top 2% JournalArticle

2 weeks ago • Science academique

Can Psychedelics Help with Alcohol Use Disorder? Current Data Says NoCan Psychedelics help with Alcohol Use Disorder (AUD): For now, the data says no.

Article

2 weeks ago • Journal of psychoactive drugs

Factors Linked to Plans to Use Psilocybin for Mental Health Compared to Therapy, Psychiatric Drugs, and Natural or Synthetic TreatmentsFactors Associated with Intentions to Use Psilocybin for Mental Health in Relation to Psychotherapy, Psychiatric Medications, and Natural/Synthetic Options.

Article

2 weeks ago • Neuroscience

Ketamine may boost the protective effects of a ketogenic diet against activity-based anorexia in adult mice by improving learning and memory circuitsKetamine enhances ketogenic diet-induced resilience to activity-based anorexia of adult mice through hippocampal synaptic plasticity.

📖 Top 20% JournalArticle

2 weeks ago • Nature communications

Serotonin-based psychedelics cause unique changes in energy use and coordination in rat brain systemsSerotonergic psychedelics induce distinct patterns of metabolic activity and covariance within biologically informed rat brain networks.

🥈 Top 2% JournalResearch Support, Non-U.S. Gov't

2 weeks ago • Bipolar disorders

Improving Ketamine Infusion Treatment for Hard-to-Treat Bipolar Depression: Comments on Zhou et al. (2023)Optimizing Ketamine Infusion Therapy for Treatment-Resistant Bipolar Depression: Commentary on Zhou et al. (2023).

Article

2 weeks ago • The Journal of clinical psychiatry

How to Use Oral Ketamine for Treating Major Depression: Key Guidelines and Practical AdviceThe Prescriber's Guide to Oral Ketamine for Patients With Major Depressive Illness: Principles and Practice.

🎖️ Top 10% JournalArticle

2 weeks ago • Nurse education today

Nursing education for new psychedelic therapy using a role-based curriculumNursing education for emerging psychedelic-assisted therapy: A role-calibrated curriculum approach.

🎖️ Top 10% JournalArticle

2 weeks ago • Medical humanities

Psychedelics in healthcare: balancing medical treatment and personal meaningPsychedelic renaissance in healthcare: between the biomedical and the existential.

📖 Top 50% JournalArticle

2 weeks ago • Journal of psychopharmacology (Oxford, England)

Different psilocybin compounds affect fentanyl reward behavior in male and female miceDifferential effects of psilocybin derivatives on fentanyl-induced conditioned place preference in male and female mice.

Article

2 weeks ago • Journal of psychopharmacology (Oxford, England)

How N,N-dimethyltryptamine behaves and affects the body, and its safety, when given by IV to healthy smokers and non-smokersPharmacokinetics, pharmacodynamics and safety of N,N-dimethyltryptamine administered intravenously in healthy smoking and non-smoking volunteers.

Article

2 weeks ago • Journal of psychopharmacology (Oxford, England)

Immediate body and mind effects of different oral and under-the-tongue psilocybin and psilocin treatments in a controlled trialA randomized crossover trial comparing the acute physiological and psychological effects of botanical formulations of oral psilocybin, oral psilocin, and sublingual psilocin.

Article

2 weeks ago • Neuroscience

Selective activation of 5-HT2A receptors changes communication and calcium signals in the hippocampusHippocampal synaptic transmission and Ca2⁺ signaling are altered by the selective 5-HT2A receptor agonist, 25CN-NBOH.

📖 Top 20% JournalArticle

2 weeks ago • Neurotoxicology

How Ketamine May Cause Memory Problems: From Brain Connections to Overall Brain Systems in PatientsAn integrative model of ketamine-induced memory dysfunction: From synapse to circuit in clinical context.

📖 Top 20% JournalArticle

3 weeks ago • Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

How a specific BDNF gene region may help ketamine provide protective effectsThe role of BDNF promoter VI in mediating protective effects of prophylactic (R,S)-ketamine.

🥉 Top 5% JournalArticle

3 weeks ago • Preventive medicine reports

Corrections to 'Changes in health behaviors after using psychedelics outside of clinical settings'Corrigendum to "Health-related behavioral changes following the use of psychedelics in naturalistic settings" [Prevent. Med. Rep. 56 (2025) 103161].

📖 Top 20% JournalPublished Erratum

3 weeks ago • The American journal of hospice & palliative care

Cancer Care Providers' Views on Therapy Using Psychedelic DrugsOncology Providers' Perspectives on Psychedelic-Assisted Therapy.

Article

3 weeks ago • European journal of drug metabolism and pharmacokinetics

Modeling how psilocybin from magic mushrooms acts in the body and brain to treat hard-to-treat depressionDevelopment of a Physiologically Based Pharmacokinetic/Pharmacodynamic Model of Psilocybin/Psilocin from Psilocybe cubensis (Magic Mushroom) in Treatment-Resistant Depression.

📖 Top 30% JournalArticle

3 weeks ago • Annals of neurology

Ketamine's potential to treat sudden muscle weakness in Narcolepsy Type 1: Evidence from a patient and mouse studyTherapeutic Prospects of Ketamine for Cataplexy in Narcolepsy Type 1: Evidence from a Human Case and a Murine Model.

🥈 Top 2% JournalArticle

3 weeks ago • Neuropsychopharmacology reports

Creating Japanese Versions of Short Questionnaires for Mystical and Difficult ExperiencesDevelopment of Japanese Versions of the 4-Item Mystical Experience Questionnaire and 7-Item Challenging Experience Questionnaire.

📖 Top 50% JournalArticle

3 weeks ago • Frontiers in psychiatry

Using active imagination and participation to support healing after psychedelic experiencesPsychedelic integration beyond the verbal: participatory-imaginal processing as a hypothesis-generating therapeutic framework.

📖 Top 20% JournalArticle

3 weeks ago • Journal of managed care & specialty pharmacy

Improving managed care strategies for hard-to-treat depressionAMCP Market Insights: Optimizing managed care approaches to treatment-resistant depression.

📖 Top 20% JournalArticle

3 weeks ago • Neuroscience of consciousness

Altered consciousness from floatation therapy in people with anxiety and depressionAquahenosis: a non-pharmacological altered state of consciousness induced by floatation-REST in individuals with anxiety and depression.

🎖️ Top 10% JournalArticle

3 weeks ago • Journal of clinical medicine

Psilocybin Therapy in Mental Health: How It Works, Uses, and New Findings (2025-2026)Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026).

📖 Top 20% JournalArticle

← prevpage 3 of 4next →

Latest Psychedelic Science Research Papers